With the cooperation of medical institutions and healthcare professionals, Chugai is committed to enhancing the transparency of, and confidence in, its corporate activities involving collaborations with medical institutions, etc.

Chugai wishes to advise that it has established “Transparency Guidelines for Chugai Activities Involving Medical Institutions, etc.”, through which it is committed to disclosing information on its corporate activities involving medical institutions, etc.

Chugai in collaboration with universities and various academic research and medical institutions engages in a range of activities including basic medical and pharmaceutical research, clinical research, postmarketing activities such as exchange and collection of safety data, collection of adverse drug reaction reports and other safety-related measures. These collaborative activities are undertaken pursuant to contracts or other instruments with medical institutions and healthcare professionals. Some of these activities may entail monetary or other forms of consideration, in the course of which Chugai has made efforts to enhance transparency not only by complying with the Pharmaceutical Affairs Law and other relevant legislation, but also with industry-led voluntary codes based on high ethical standards such as those laid down in the Japan Pharmaceutical Manufacturers Association’s (hereinafter, JPMA) Charter of Corporate Behaviour, the Compliance Program/Guideline, Promotion Code for Prescription Drugs and the Fair Competition Code on Premium Offers by the Ethical Drug Manufacturing Industry.

Efforts to address conflict of interest issues are already in progress overseas and in Japan through various activities by the Ministry of Education, Culture, Sports, Science and Technology, the Ministry of Health, Labour and Welfare, medical societies and other bodies. Chugai, therefore aims to establish an even greater reputation in the community for reliability, and has committed to developing its own guidelines on transparency in its activities with medical institutions and healthcare professionals, and to strengthening its internal structure and disclosing information appropriately.

Chugai will take advantage of the opportunity presented by the establishment of these guidelines to aim for even greater transparency in its corporate activities. Medical institutions and healthcare professionals are urged to cooperate with Chugai and understand the principles upon which these guidelines were established.